Compare AANJANEYA LIFECARE with AJANTA PHARMA - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DR. DATSONS LABS vs AJANTA PHARMA - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DR. DATSONS LABS AJANTA PHARMA DR. DATSONS LABS/
AJANTA PHARMA
 
P/E (TTM) x -10.9 24.6 - View Chart
P/BV x 0.2 6.8 2.4% View Chart
Dividend Yield % 0.0 0.5 -  

Financials

 DR. DATSONS LABS   AJANTA PHARMA
EQUITY SHARE DATA
    DR. DATSONS LABS
Mar-14
AJANTA PHARMA
Mar-19
DR. DATSONS LABS/
AJANTA PHARMA
5-Yr Chart
Click to enlarge
High Rs1261,422 8.8%   
Low Rs31898 3.4%   
Sales per share (Unadj.) Rs133.0233.5 57.0%  
Earnings per share (Unadj.) Rs0.244.0 0.3%  
Cash flow per share (Unadj.) Rs6.652.2 12.7%  
Dividends per share (Unadj.) Rs09.00 0.0%  
Dividend yield (eoy) %00.8 0.0%  
Book value per share (Unadj.) Rs128.8255.1 50.5%  
Shares outstanding (eoy) m31.6688.02 36.0%   
Bonus/Rights/Conversions FCCBBB-  
Price / Sales ratio x0.65.0 11.8%   
Avg P/E ratio x516.126.4 1,956.5%  
P/CF ratio (eoy) x11.822.2 53.3%  
Price / Book Value ratio x0.64.5 13.4%  
Dividend payout %020.5 0.0%   
Avg Mkt Cap Rs m2,477102,081 2.4%   
No. of employees `000NA6.8 0.0%   
Total wages/salary Rs m564,307 1.3%   
Avg. sales/employee Rs ThNM3,022.6-  
Avg. wages/employee Rs ThNM633.4-  
Avg. net profit/employee Rs ThNM569.1-  
INCOME DATA
Net Sales Rs m4,21120,554 20.5%  
Other income Rs m79211 37.3%   
Total revenues Rs m4,28920,765 20.7%   
Gross profit Rs m5695,664 10.0%  
Depreciation Rs m204721 28.4%   
Interest Rs m43012 3,708.6%   
Profit before tax Rs m135,143 0.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m-20-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m61,273 0.5%   
Profit after tax Rs m53,870 0.1%  
Gross profit margin %13.527.6 49.0%  
Effective tax rate %48.024.8 194.0%   
Net profit margin %0.118.8 0.6%  
BALANCE SHEET DATA
Current assets Rs m6,85211,812 58.0%   
Current liabilities Rs m6,7113,776 177.7%   
Net working cap to sales %3.339.1 8.6%  
Current ratio x1.03.1 32.6%  
Inventory Days Days16177 207.9%  
Debtors Days Days31882 390.3%  
Net fixed assets Rs m3,67314,398 25.5%   
Share capital Rs m317175 180.5%   
"Free" reserves Rs m3,76122,277 16.9%   
Net worth Rs m4,07822,452 18.2%   
Long term debt Rs m1,6717 25,315.2%   
Total assets Rs m12,63326,962 46.9%  
Interest coverage x1.0444.3 0.2%   
Debt to equity ratio x0.40 139,393.8%  
Sales to assets ratio x0.30.8 43.7%   
Return on assets %3.414.4 23.9%  
Return on equity %0.117.2 0.7%  
Return on capital %7.723.0 33.4%  
Exports to sales %22.90-   
Imports to sales %14.30-   
Exports (fob) Rs m964NA-   
Imports (cif) Rs m602NA-   
Fx inflow Rs m96410,682 9.0%   
Fx outflow Rs m6072,102 28.9%   
Net fx Rs m3578,580 4.2%   
CASH FLOW
From Operations Rs m1,3453,748 35.9%  
From Investments Rs m-2,256-2,228 101.2%  
From Financial Activity Rs m-1,200-1,475 81.4%  
Net Cashflow Rs m-2,11145 -4,669.7%  

Share Holding

Indian Promoters % 4.5 73.8 6.1%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 1.6 -  
FIIs % 1.4 7.6 17.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 94.1 17.0 553.5%  
Shareholders   20,807 20,968 99.2%  
Pledged promoter(s) holding % 0.0 4.4 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DR. DATSONS LABS With:   ALKEM LABORATORIES  STRIDES PHARMA SCIENCE  J.B.CHEMICALS  TORRENT PHARMA  DISHMAN PHARMA  

Compare DR. DATSONS LABS With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 257 Points Higher, Coal India and UPL Among Top Gainers(Closing)

Indian share markets continued their positive trend during closing hours today and ended their day on a firm note.

Related Views on News

AJANTA PHARMA Announces Quarterly Results (3QFY21); Net Profit Up 64.2% (Quarterly Result Update)

Feb 5, 2021 | Updated on Feb 5, 2021

For the quarter ended December 2020, AJANTA PHARMA has posted a net profit of Rs 2 bn (up 64.2% YoY). Sales on the other hand came in at Rs 7 bn (up 15.0% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.

AJANTA PHARMA Announces Quarterly Results (2QFY21); Net Profit Up 46.3% (Quarterly Result Update)

Nov 6, 2020 | Updated on Nov 6, 2020

For the quarter ended September 2020, AJANTA PHARMA has posted a net profit of Rs 2 bn (up 46.3% YoY). Sales on the other hand came in at Rs 7 bn (up 11.4% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.

AJANTA PHARMA Announces Quarterly Results (1QFY21); Net Profit Up 28.9% (Quarterly Result Update)

Aug 24, 2020 | Updated on Aug 24, 2020

For the quarter ended June 2020, AJANTA PHARMA has posted a net profit of Rs 1 bn (up 28.9% YoY). Sales on the other hand came in at Rs 7 bn (up 9.2% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.

AJANTA PHARMA Announces Quarterly Results (4QFY20); Net Profit Up 45.3% (Quarterly Result Update)

May 21, 2020 | Updated on May 21, 2020

For the quarter ended March 2020, AJANTA PHARMA has posted a net profit of Rs 1 bn (up 45.3% YoY). Sales on the other hand came in at Rs 7 bn (up 32.4% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.

AJANTA PHARMA Announces Quarterly Results (3QFY20); Net Profit Up 60.8% (Quarterly Result Update)

Feb 6, 2020 | Updated on Feb 6, 2020

For the quarter ended December 2019, AJANTA PHARMA has posted a net profit of Rs 1 bn (up 60.8% YoY). Sales on the other hand came in at Rs 7 bn (up 34.2% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.

More Views on News

Most Popular

Intraday Trading for a Living(Fast Profits Daily)

Feb 15, 2021

In this video, I'll cover your queries on intraday trading and also share my view on how to decide stop losses and target prices.

Penny Stock Master Series: The Quest for 10X Profits in 10 Years(Profit Hunter)

Feb 12, 2021

This is first of the three part master series. In these editorials, I'll show you how to earn 10X returns from a penny stock portfolio over 10 years.

Top 5 Stocks Mutual Funds Bought and Sold in January 2021(Sector Info)

Feb 16, 2021

A look at what India's top equity mutual funds bought and sold in January 2021.

I Would Recommend this Small-cap Stock Over Tesla(Profit Hunter)

Feb 16, 2021

Do you enjoy reading Tesla and Bitcoin stories? Here's a not so famous small-cap stock to profit from the rise of EVs.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

DR. DATSONS LABS SHARE PRICE


May 21, 2015 (Close)

TRACK DR. DATSONS LABS

  • Track your investment in DR. DATSONS LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DR. DATSONS LABS

DR. DATSONS LABS 5-YR ANALYSIS

COMPARE DR. DATSONS LABS WITH

MARKET STATS